Tag Archives: Axcella Health

Axcella Health (AXLA) Gets a Buy Rating from Wedbush

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Axcella Health (AXLA – Research Report), with a price target of $19.00. The company’s shares closed last Thursday at $5.16. According to TipRanks.com, Moussatos is a

Axcella Health (AXLA) Received its Third Buy in a Row

After Goldman Sachs and Piper Sandler gave Axcella Health (NASDAQ: AXLA) a Buy rating last month, the company received another Buy, this time from Wedbush. Analyst Liana Moussatos reiterated a Buy rating on Axcella Health today and set a price

Goldman Sachs Sticks to Their Buy Rating for Axcella Health (AXLA)

Goldman Sachs analyst Paul Choi reiterated a Buy rating on Axcella Health (AXLA – Research Report) on August 5 and set a price target of $9.00. The company’s shares closed last Tuesday at $5.48. According to TipRanks.com, Choi is a

Axcella Health (AXLA) Receives a Buy from Leerink Partners

In a report released today, Geoff Porges from Leerink Partners maintained a Buy rating on Axcella Health (AXLA – Research Report), with a price target of $10.00. The company’s shares closed last Thursday at $5.15. According to TipRanks.com, Porges is

BTIG Reiterates Buy on Axcella Health Shares, Sees 211% Upside For The Stock

In a research report published on Sunday, BTIG analyst Julian Harrison reiterated a Buy rating on Axcella Health (NASDAQ:AXLA)with a price target of $16, which implies an upside of 211% from current levels. With a return potential of 443.7%, the

Axcella Health (AXLA) Has a New Rating from Wedbush

Wedbush analyst Liana Moussatos initiated coverage with a Buy rating on Axcella Health (AXLA – Research Report) today and set a price target of $28.00. The company’s shares closed last Wednesday at $5.19. According to TipRanks.com, Moussatos is a 4-star